As the scale of Pune’s Guillain-Barré Syndrome (GBS) outbreak grows, with the number of cases rising to 101, there is much curiosity around the prognosis and treatment of the rare condition. Speaking ...

Annexon, Inc. (NASDAQ:ANNX) on Tuesday presented data for its late-stage targeted therapy, tanruprubart (formerly ANX005), for Guillain-Barré Syndrome (GBS). GBS is a neuromuscular emergency affecting ...

A Virginia man, Ra-Jon James, has shared his inspiring story of recovery after miraculously going from complete paralysis to ...

Please provide your email address to receive an email when new articles are posted on . Results from a phase 2 clinical trial showed that treatment with an IgG-cleaving enzyme for individuals ...